ii)

i)

kk)

i

mm)

mn)

00)

pp)
qq)

ir)

ss)

tt)

uu)

Gangadi Investments Private Limited and certain individual shareholders of our Company, as amended by
waiver cum amendment agreement dated August 5, 2021.

Share purchase agreement dated December 24, 2019 entered into amongst PI Opportunities Fund — 1, Gangadi
Madhukar Reddy, Gangadi Investments Private Limited and our Company

Share purchase agreement dated December 24, 2019 entered into amongst Gangadi Investments Private
Limited, S S Pharma LLC, Shore Pharma LLC, Natco Pharma Limited, Time Cap Pharma Labs Limited and
our Company.

Share purchase agreement dated December 24, 2020 entered into amongst Lavender Rose Investment Ltd,
Gangadi Madhukar Reddy, Gangadi Investments Private Limited, Agilemed Investments Private Limited,
Lone Furrow Investments Private Limited and our Company

Share subscription agreement dated February 22, 2019 entered into amongst PI Opportunities Fund — I,
Gangadi Madhukar Reddy, Gangadi Investments Private Limited and our Company.

Share subscription agreement dated December 24, 2020 entered into amongst Lavender Rose Investment Ltd,
Agilemed Investments Private Limited, Lone Furrow Investments Private Limited, Gangadi Madhukar
Reddy, Gangadi Investments Private Limited and our Company.

Share subscription agreement dated December 24, 2020 entered into amongst PI Opportunities Fund - I,
Agilemed Investments Private Limited, Lone Furrow Investments Private Limited, Gangadi Madhukar
Reddy, Gangadi Investments Private Limited and our Company.

Inter-investor agreement dated January 27, 2021 entered into between Morning Brook Investment Ltd, Zash
Traders, Vistra ITCL (India) Limited, PI Opportunities Fund — I, Lavender Rose Investment Ltd, Gangadi
Madhukar Reddy, Gangadi Investments Private Limited, Agilemed Investments Private Limited, Lone
Furrow Investments Private Limited and the Company, as amended by waiver cum amendment agreement
dated August 5, 2021.

User agreement dated March 1, 2019 entered into between Optival and our Company.

Agreement dated January 25, 2021 entered into between PI Opportunities Fund — I, Lavender Rose
Investment Ltd, Gangadi Madhukar Reddy, Gangadi Investments Private Ltd, Agilemed Investments Private
Limited and Lone Furrow Investments Private Limited, as amended by waiver cum amendment agreement
dated August 5, 2021.

Letters dated August 6, 2021 and August 6, 2021 issued by Zash Debenture Trustee and Morning Brook
Debenture Trustee, respectively, in relation to the pledge over the preference shares held by our Corporate
Promoter along with the modification letters dated November 24, 2021 and November 25, 2021

Scheme of amalgamation between Optival, Ritemed and their respective shareholders and creditors, under
Section 233 and certain other provisions of the Companies Act, 2013 filed with the RoC on October 3, 2018
pursuant to which Ritemed amalgamated with Optival

Settlement letter dated November 27, 2021 issued by G. Madhukar Reddy, Lone Furrow Investments Private
Limited, Agilemed Investments Private Limited, Gangadi Investments Private Limited to PI Opportunities
Fund —1

SEBI observation letter dated November 17, 2021 bearing SEBI Reference Number
SEBI/HO/CFD/DIL2/P/OW/2021/33146/1.

Any of the contracts or documents mentioned in this Prospectus may be amended or modified at any time if so required in the
interest of our Company or if required by the other parties, without notice to the Shareholders subject to compliance of the
provisions contained in the Companies Act and other relevant statutes.

365
